-
Mashup Score: 5BISON-PRO Quality of Life Study - 8 day(s) ago
A prospective repository of longitudinal, real-world patient-reported outcomes (PRO) and quality of life data for patients with blood disorders.
Source: bison-pro.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2Ajay Major: CTCL global QOL scores and pruritis improve in both responders and non-responders - OncoDaily - 17 day(s) ago
Ajay Major: CTCL global QOL scores and pruritis improve in both responders and non-responders / Ajay Major, ASH, ASH24, cancer, CTCL symptoms, OncoDaily,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: CTCL global QOL scores and pruritis improve in both responders and non-responders - @majorajay https://t.co/y98djKaCYY #A…
-
-
Mashup Score: 0Paper: A Healthcare Utilization Model Comparing Time Toxicity between Glofitamab and Epcoritamab - 17 day(s) ago
Program: Oral and Poster Abstracts Session: 902. Health Services and Quality Improvement: Lymphoid Malignancies: Poster II Hematology Disease Topics & Pathways: Research, Lymphomas, Non-Hodgkin lymphoma, Bispecific Antibody Therapy, Clinical Research, Health outcomes research, Diseases, Indolent lymphoma, Real-world evidence, Treatment Considerations, Biological therapies, Lymphoid Malignancies Pallawi Torka, MD 1, Anthony Masaquel 2 *, Lourenia Cassoli 2 *, David Fox 2 *, Arliene Ravelo 2 * and Ajay
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
Many thanks to Dr. @PallawiTorkaMD for your collaboration and to Dr. @guptaarjun90 for pioneering time toxicity as a patient-centered outcome! #ASH24 #lymsm Abstract link: https://t.co/4QLhfdOEev https://t.co/ScpdoKnggJ
-
-
Mashup Score: 4Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients - 19 day(s) ago
Sickle cell disease (SCD) poses significant challenges for patients, particularly through vaso-occlusive pain crises (VOC). Our study of 1000 SCD patients in high-prevalence states in India highlight…
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet-
PROs #ASH24 Ham-Wasserman Lecture on #SCD in India: 1000 pts across 14 sites - sig worse utility & multiple QOL domains if VOC in prior yr - in pediatric pts, multiple concerns regarding mobility and school attendance Full paper: https://t.co/MFiC0tZA9c #MajorPROsASH #ConquerSCD https://t.co/s0F5VCAtOl
-
-
Mashup Score: 5BISON-PRO Quality of Life Study - 19 day(s) ago
A prospective repository of longitudinal, real-world patient-reported outcomes (PRO) and quality of life data for patients with blood disorders.
Source: bison-pro.orgCategories: General Medicine News, Hem/OncsTweet-
Of course we have branded gear for our BISON-PRO Quality of Life Study! We're collecting longitudinal patient-reported outcomes surveys from folks with blood disorders @CUAnschutz @uchealth. Learn more about the @CUCancerCenter study at https://t.co/BhuYULJjic. #qualityoflife https://t.co/ATSgzShU9b
-
-
Mashup Score: 18In pursuit of a functional cure for follicular lymphoma - 19 day(s) ago
Abstract. We are now a quarter of a century after the transformative impact of rituximab in improving overall survival for patients with follicular lymphom
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet-
That feeling when your PRO study gets cited in an @ASH_hematology Education Program article!🤩 Thank you to @JudithTrotman1 for highlighting our work as part of a larger research program to utilize PROs in iNHL management & decision-making. #ASH24 #lymsm https://t.co/3mtF8cGG1W https://t.co/hoVZwuCNvE
-
-
Mashup Score: 6Join us for the Denver ASH Review! - 21 day(s) ago
Experts in blood cancers and disorders provide exciting updates from ASH 2023 with a focus on the latest treatment advances relevant to your clinical practice.
Source: denverashreview.comCategories: General Medicine News, Hem/OncsTweet-
RT @CUHematology: We invite you to join us in a few weeks for 2024's Denver ASH Review! https://t.co/T5DAzZLnGp In-person OR online -- re…
-
-
Mashup Score: 40Ajay Major, MD, MBA (@majorajay) on X - 24 day(s) ago
Lymphoma/CLL faculty @CUMedicalSchool. Patient-reported outcomes methodologist & #lymsm quality of life investigator. Founder of https://t.co/kN6qeGFEox.
Source: x.comCategories: General Medicine News, Hem/OncsTweet-
Honored to be featured on the @ASH_hematology ASH News Daily #ASH24 follow list! I'll be posting on both my Twitter (https://t.co/pBq7uWDQqK) and BS (https://t.co/1nydU5Y50B), so please do follow! https://t.co/selJAN38rm https://t.co/6W4XMWm40V
-
-
Mashup Score: 5Hearts of Hematology - Hematology.org - 1 month(s) ago
Hearts of Hematology
Source: www.hematology.orgCategories: General Medicine News, Hem/OncsTweet-
Wonderful to see Hematopoiesis (the @ASH_hematology Trainee Council publication we founded in 2021) creating an new #narrativemedicine section entitled 'Hearts of Hematology.' Congratulations to @Anika_s_Patel and the Trainee Council! #meded #HeartsofHeme https://t.co/bnsTRZCiZv https://t.co/rSNvZGN0xQ
-
-
Mashup Score: 3
Program: Oral and Poster Abstracts Session: 628. Aggress ive Lymphomas: Cellular Therapies: Poster III 1 University of Colorado, Denver, CO 2 Division of Hematology, University of Colorado, Aurora, CO 3 Center for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO 4 Dept. of Pediatric Hematology/Oncology & BMT, Nationwide Children’s Hospital, Columbus, OH 5 Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, CO 6 University of Colorado, Anschutz Medical Campus,
Source: ash.confex.comCategories: General Medicine News, Hem/OncsTweet-
CD19x22 CAR R/R NHL @mana1981 #ASH24: - 9 pts, all LBCL, mLOT 3 (2 prior CAR, 22% prior BsAbs) - 55% CRS, 22% ICANS (none G3+), 1 G5 IEC-HS - med time to CRS 9d, ICANS 18d - 2/8 CR, 1/8 PR Unique toxicity profile & trajectories. #lymsm #celltherapy https://t.co/zmVK38FmR7 https://t.co/poWRTWEyzo
-
Of course we have branded gear for our BISON-PRO Quality of Life Study! We're collecting longitudinal patient-reported outcomes surveys from folks with blood disorders @CUAnschutz @uchealth. Learn more about the @CUCancerCenter study at https://t.co/BhuYULJjic. #qualityoflife https://t.co/ATSgzShU9b